Pediatric drug development: concepts and applications
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
Hoboken, N.J.
Wiley
2013
|
Ausgabe: | 2nd ed |
Schlagworte: | |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | xiv, 610 p. |
ISBN: | 9781118312063 9781118312056 9781118312131 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV044175823 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 170217s2013 |||| o||u| ||||||eng d | ||
020 | |a 9781118312063 |9 978-1-118-31206-3 | ||
020 | |a 9781118312056 |9 978-1-118-31205-6 | ||
020 | |a 9781118312131 |c Online |9 978-1-118-31213-1 | ||
035 | |a (ZDB-30-PAD)EBC1204055 | ||
035 | |a (ZDB-89-EBL)EBL1204055 | ||
035 | |a (OCoLC)910720322 | ||
035 | |a (DE-599)BVBBV044175823 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
082 | 0 | |a 615.190083 |2 23 | |
245 | 1 | 0 | |a Pediatric drug development |b concepts and applications |c editors, Andrew E. Mulberg ... [et al.] |
250 | |a 2nd ed | ||
264 | 1 | |a Hoboken, N.J. |b Wiley |c 2013 | |
300 | |a xiv, 610 p. | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
505 | 0 | |a pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls | |
650 | 4 | |a Pediatric pharmacology | |
650 | 4 | |a Drug development | |
700 | 1 | |a Mulberg, Andrew E. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-118-31215-5 |
912 | |a ZDB-30-PAD | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-029582668 |
Datensatz im Suchindex
_version_ | 1804177297229479936 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV044175823 |
collection | ZDB-30-PAD |
contents | pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls |
ctrlnum | (ZDB-30-PAD)EBC1204055 (ZDB-89-EBL)EBL1204055 (OCoLC)910720322 (DE-599)BVBBV044175823 |
dewey-full | 615.190083 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.190083 |
dewey-search | 615.190083 |
dewey-sort | 3615.190083 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | 2nd ed |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01706nmm a2200385zc 4500</leader><controlfield tag="001">BV044175823</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118312063</subfield><subfield code="9">978-1-118-31206-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118312056</subfield><subfield code="9">978-1-118-31205-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118312131</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-118-31213-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC1204055</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL1204055</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)910720322</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044175823</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.190083</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pediatric drug development</subfield><subfield code="b">concepts and applications</subfield><subfield code="c">editors, Andrew E. Mulberg ... [et al.]</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">Wiley</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 610 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pediatric pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mulberg, Andrew E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-118-31215-5</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029582668</subfield></datafield></record></collection> |
id | DE-604.BV044175823 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:45:50Z |
institution | BVB |
isbn | 9781118312063 9781118312056 9781118312131 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029582668 |
oclc_num | 910720322 |
open_access_boolean | |
physical | xiv, 610 p. |
psigel | ZDB-30-PAD |
publishDate | 2013 |
publishDateSearch | 2013 |
publishDateSort | 2013 |
publisher | Wiley |
record_format | marc |
spelling | Pediatric drug development concepts and applications editors, Andrew E. Mulberg ... [et al.] 2nd ed Hoboken, N.J. Wiley 2013 xiv, 610 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls Pediatric pharmacology Drug development Mulberg, Andrew E. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-1-118-31215-5 |
spellingShingle | Pediatric drug development concepts and applications pt. I. Past, present, and future of pediatric drug development -- pt. II. Ethical underpinnings -- pt. III. Regulatory guidelines for pediatric drug development -- pt. IV. Preclinical safety assessment -- pt. V. Pharmacological principles in pediatric drug development -- pt. VI. Clinical trial operations -- pt. VII. Clinical trial operations and good clinical trials -- pt. VIII. Clinical efficacy and safety endpoints -- pt. IX. Formulation, chemistry and manufacturing controls Pediatric pharmacology Drug development |
title | Pediatric drug development concepts and applications |
title_auth | Pediatric drug development concepts and applications |
title_exact_search | Pediatric drug development concepts and applications |
title_full | Pediatric drug development concepts and applications editors, Andrew E. Mulberg ... [et al.] |
title_fullStr | Pediatric drug development concepts and applications editors, Andrew E. Mulberg ... [et al.] |
title_full_unstemmed | Pediatric drug development concepts and applications editors, Andrew E. Mulberg ... [et al.] |
title_short | Pediatric drug development |
title_sort | pediatric drug development concepts and applications |
title_sub | concepts and applications |
topic | Pediatric pharmacology Drug development |
topic_facet | Pediatric pharmacology Drug development |
work_keys_str_mv | AT mulbergandrewe pediatricdrugdevelopmentconceptsandapplications |